The Effect of On-line High-flux Hemofiltration Versus Low-flux Hemodialysis on Mortality in Chronic Kidney Failure: A Small Randomized Controlled Trial
Received 26 October 2007; accepted 12 May 2008. published online 10 July 2008.
Refers to article:
“Artificial” Hemodialysis Versus “Natural” Hemofiltration
Thomas A. Depner
American Journal of Kidney Diseases
September 2008 (Vol. 52, Issue 3, Pages 403-406) Full Text |
Full-Text PDF (66 KB)
Background
Given the paucity of prospective randomized controlled trials assessing comparative performances of different dialysis techniques, we compared on-line high-flux hemofiltration (HF) with ultrapure low-flux hemodialysis (HD), assessing survival and morbidity in patients with end-stage renal disease (ESRD).
Study Design
An investigator-driven, prospective, multicenter, 3-year-follow-up, centrally randomized study with no blinding and based on the intention-to-treat principle.
Setting & Participants
Prevalent patients with ESRD (age, 16 to 80 years; vintage > 6 months) receiving renal replacement therapy at 20 Italian dialysis centers.
Interventions
Patients were centrally randomly assigned to HD (n = 32) or HF (n = 32).
Outcomes & Measurements
All-cause mortality, hospitalization rate for any cause, prevalence of dialysis hypotension, standard biochemical indexes, and nutritional status. Analyses were performed using the multivariate analysis of variance and Cox proportional hazard method.
Results
There was significant improvement in survival with HF compared with HD (78%, HF versus 57%, HD) at 3 years of follow-up after allowing for the effects of age (P = 0.05). End-of-treatment Kt/V was significantly higher with HD (1.42 ± 0.06 versus 1.07 ± 0.06 with HF), whereas β2-microglobulin levels remained constant in HD patients (33.90 ± 2.94 mg/dL at baseline and 36.90 ± 5.06 mg/dL at 3 years), but decreased significantly in HF patients (30.02 ± 3.54 mg/dL at baseline versus 23.9 ± 1.77 mg/dL; P < 0.05). The number of hospitalization events for each patient was not significantly different (2.36 ± 0.41 versus 1.94 ± 0.33 events), whereas length of stay proved to be significantly shorter in HF patients compared with HD patients (P < 0.001). End-of-treatment body mass index decreased in HD patients, but increased in HF patients. Throughout the study period, the difference in trends of intradialytic acute hypotension was statistically significant, with a clear decrease in HF (P = 0.03).
Limitations
This is a small preliminary intervention study with a high dropout rate and problematic generalizability.
Conclusion
On-line HF may improve survival independent of Kt/V in patients with ESRD, with a significant decrease in plasma β2-microglobulin levels and increased body mass index. A larger study is required to confirm these results.
8Ospedale S Maria della Scaletta, Imola, Bologna, Italy
9Department of Pharmacology and Epidemiology, Mario Negri Sud Consortium, S Maria Imbaro, Chieti, Italy
10DIAVERUM Medical-Scientific Office, Lund, Sweden
Address correspondence to Antonio Santoro, MD, Department of Nephrology Dialysis Hypertension, Policlinico S Orsola-Malpighi, Via P Palagi 9, 40138 Bologna, Italy
ABSTRACT